How to Prioritize Roles and Responsibilities in the Lung Cancer Patient Journey

Presented by

AONN

Sponsored by

AstraZeneca

The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to introduce an educational video in which expert nurse navigators and nurse practitioners discuss how they prioritize their many roles and responsibilities in the lung cancer patient journey.

This video is part 1 of a 5-part educational video series we’ve produced in partnership with AstraZeneca. Topics of discussion in this video include:

  • In your opinion, where are you most essential within the lung cancer patient journey?
  • How do you prioritize the many responsibilities that you have with your patients?
  • What do you most want community nurse navigators and nurse practitioners to know about treating patients with lung cancer?

How to Prioritize Roles and Responsibilities in the Lung Cancer Patient Journey

Lung Cancer Education Resources
Benjamin Levy, MD
Rasheda Persinger, MSN, NP-C
Holly Chitwood
Kim Rohan, ANP-BC, AOCN
Lauren Welch, MSN, NP-C, AOCNP
Claudia T. Miller, BSN, RN, OCN, ONN-CG

Panelists include:

Benjamin Levy, MD Benjamin Levy, MD
Associate Professor
Johns Hopkins School of Medicine
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital
Rasheda Persinger, MSN, NP-C Rasheda Persinger, MSN, NP-C
Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital
Holly Chitwood, DNP, APRN, FNP-C, AGACNP-BC Holly Chitwood, DNP, APRN, FNP-C, AGACNP-BC
University of Kentucky Markey Cancer Center
Kim Rohan, ANP-BC, AOCN Kim Rohan, ANP-BC, AOCN
Edward Hospital & Health Services
Lauren Welch, MSN, NP-C, AOCNP Lauren Welch, MSN, NP-C, AOCNP
Tennessee Oncology/Sarah Cannon Research Institute
Claudia Miller, BSN, RN, OCN, ONN-CG Claudia Miller, BSN, RN, OCN, ONN-CG
Medical University of South Carolina

DISCLAIMER

The views and opinions expressed in this video are those of the individual oncology specialists and do not represent the views or opinions of AstraZeneca. This video contains anecdotal information gathered from a discussion with oncology specialists based on their opinions/experiences. Recommendations are general and may vary with patients. At the time of the filming, the healthcare professionals featured were in the roles and at the institutions indicated.

Related Articles
Keeping Patients on Track Throughout the Unresectable Stage III Treatment Journey
Benjamin Levy, MD, Kim Rohan, ANP-BC, AOCN, Lauren Welch, MSN, NP-C, AOCNP, Claudia T. Miller, BSN, RN, OCN, ONN-CG, Rasheda Persinger, MSN, NP-C
|
Lung Cancer Education Resources
Helping to Support Optimal Care in Small Cell Lung Cancer
Benjamin Levy, MD, Holly Chitwood, Kim Rohan, ANP-BC, AOCN, Lauren Welch, MSN, NP-C, AOCNP, Claudia T. Miller, BSN, RN, OCN, ONN-CG
|
Lung Cancer Education Resources
Availability and Accessibility of Cancer Care Delivery Approaches to Reduce Financial Toxicity of Rural and Urban Cancer Patients in Kentucky
Jean Edward, PhD, RN, CHPE, William Bowling, BA, Holly Chitwood, Robin Vanderpool, DrPH
|
May 2022 Vol 13, No 5
A study of healthcare staff perspectives of financial toxicity experienced by cancer patients and staff- and systems-level cancer care delivery approaches for addressing financial toxicity.
Last modified: August 10, 2023

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country